504 related articles for article (PubMed ID: 20650978)
21. Alpha-1 antitrypsin: now available, but do we need it?
Russi EW
Swiss Med Wkly; 2008 Apr; 138(13-14):191-6. PubMed ID: 18389391
[TBL] [Abstract][Full Text] [Related]
22. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial.
Chapman KR; Burdon JG; Piitulainen E; Sandhaus RA; Seersholm N; Stocks JM; Stoel BC; Huang L; Yao Z; Edelman JM; McElvaney NG;
Lancet; 2015 Jul; 386(9991):360-8. PubMed ID: 26026936
[TBL] [Abstract][Full Text] [Related]
23. Short-term supplementation therapy does not affect elastin degradation in severe alpha(1)-antitrypsin deficiency. The American-Italian AATD Study Group.
Gottlieb DJ; Luisetti M; Stone PJ; Allegra L; Cantey-Kiser JM; Grassi C; Snider GL
Am J Respir Crit Care Med; 2000 Dec; 162(6):2069-72. PubMed ID: 11112116
[TBL] [Abstract][Full Text] [Related]
24. Improving diagnosis and management of alpha-1 antitrypsin deficiency in primary care: translating knowledge into action.
Fromer L
COPD; 2010 Jun; 7(3):192-8. PubMed ID: 20486818
[TBL] [Abstract][Full Text] [Related]
25. The discovery of α1-antitrypsin and its role in health and disease.
Janciauskiene SM; Bals R; Koczulla R; Vogelmeier C; Köhnlein T; Welte T
Respir Med; 2011 Aug; 105(8):1129-39. PubMed ID: 21367592
[TBL] [Abstract][Full Text] [Related]
26. Augmentation therapy of alpha 1-antitrypsin deficiency.
Hubbard RC; Crystal RG
Eur Respir J Suppl; 1990 Mar; 9():44s-52s. PubMed ID: 2340051
[TBL] [Abstract][Full Text] [Related]
27. Alpha 1-antitrypsin augmentation therapy.
Sandhaus RA
Agents Actions Suppl; 1993; 42():97-102. PubMed ID: 8356934
[TBL] [Abstract][Full Text] [Related]
28. The role of augmentation therapy in alpha-1 antitrypsin deficiency.
Kueppers F
Curr Med Res Opin; 2011 Mar; 27(3):579-88. PubMed ID: 21226542
[TBL] [Abstract][Full Text] [Related]
29. [Long-term therapy of alpha 1-antitrypsin-deficiency-associated pulmonary emphysema with human alpha 1-antitrypsin].
Wencker M; Banik N; Buhl R; Seidel R; Konietzko N
Pneumologie; 1998 Oct; 52(10):545-52. PubMed ID: 9847632
[TBL] [Abstract][Full Text] [Related]
30. Alpha-1 antitrypsin deficiency: new developments in augmentation and other therapies.
Turner AM
BioDrugs; 2013 Dec; 27(6):547-58. PubMed ID: 23771682
[TBL] [Abstract][Full Text] [Related]
31. Alpha-1 antitrypsin (AAT) augmentation therapy in individuals with the PI*MZ genotype: a pro/con debate on a working hypothesis.
Barjaktarevic I; Miravitlles M
BMC Pulm Med; 2021 Mar; 21(1):99. PubMed ID: 33757485
[TBL] [Abstract][Full Text] [Related]
32. α1-Antitrypsin Deficiency.
Hatipoğlu U; Stoller JK
Clin Chest Med; 2016 Sep; 37(3):487-504. PubMed ID: 27514595
[TBL] [Abstract][Full Text] [Related]
33. [Expert statement for augmentation therapy in patients with alpha-1 antitrypsin deficiency].
Köhnlein T; Schmidt-Scherzer K; Greulich T; Bals R
Pneumologie; 2014 Jul; 68(7):492-5. PubMed ID: 25006842
[TBL] [Abstract][Full Text] [Related]
34. Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema.
Wewers MD; Casolaro MA; Sellers SE; Swayze SC; McPhaul KM; Wittes JT; Crystal RG
N Engl J Med; 1987 Apr; 316(17):1055-62. PubMed ID: 3494198
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of alpha1-antitrypsin augmentation therapy in conditions other than pulmonary emphysema.
Blanco I; Lara B; de Serres F
Orphanet J Rare Dis; 2011 Apr; 6():14. PubMed ID: 21486454
[TBL] [Abstract][Full Text] [Related]
36. Reduction of severe exacerbations and hospitalization-derived costs in alpha-1-antitrypsin-deficient patients treated with alpha-1-antitrypsin augmentation therapy.
Barros-Tizón JC; Torres ML; Blanco I; Martínez MT;
Ther Adv Respir Dis; 2012 Apr; 6(2):67-78. PubMed ID: 22354900
[TBL] [Abstract][Full Text] [Related]
37. Alpha-1-antitrypsin deficiency.
Bals R
Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):629-33. PubMed ID: 20955965
[TBL] [Abstract][Full Text] [Related]
38. Clinical utility of alpha-1 proteinase inhibitor in the management of adult patients with severe alpha-1 antitrypsin deficiency: a review of the current literature.
Parr DG; Lara B
Drug Des Devel Ther; 2017; 11():2149-2162. PubMed ID: 28769553
[TBL] [Abstract][Full Text] [Related]
39. Alpha1-antitrypsin review.
Stockley RA
Clin Chest Med; 2014 Mar; 35(1):39-50. PubMed ID: 24507836
[TBL] [Abstract][Full Text] [Related]
40. Aralast: an alpha 1-protease inhibitor for the treatment of alpha-antitrypsin deficiency.
Mordwinkin NM; Louie SG
Expert Opin Pharmacother; 2007 Oct; 8(15):2609-14. PubMed ID: 17931094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
